Master One Thing - Rapamycin Longevity Series cover image

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

Master One Thing - Rapamycin Longevity Series

00:00

Designing the First Human Aging Trial

Joan explains choosing immune function and flu vaccine response as a short-term aging endpoint.

Play episode from 23:35
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app